Pakistan Stock Exchange (PSX) · Pakistan · Updated after 27 Oct 2026 close
Liven Pharma
LIVEN · Pakistan Stock Exchange (PSX) · prices in PKR
PKR 30.94▲ +0.44 (1.44%)
About Liven Pharma
Liven Pharma Limited is a Lahore-based pharmaceutical manufacturer whose main business is making medicines and allied products. Pharmaceuticals are medicinal products made for treating and preventing illness, and allied products cover related goods that support health care. The company carries out this manufacturing as its principal activity.
On this site Liven Pharma appears as a stock on the Pakistan Stock Exchange (PSX), code LIVEN, with prices in Pakistani rupees (PKR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #531 of 542 on the Pakistan Stock Exchange (PSX) · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Pakistan yet.
TrendWeak
11/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-17.7%
From 52-week high-53.9%
MomentumWeak
18/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-15.1%
6-month return-22.4%
12-month, skipping last month-48.9%
Stability (higher is calmer)Weak
27/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)52.3%
Worst drawdown, 1 year (smaller is calmer)-57.0%
LiquidityWeak
30/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded1.15M PKR
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Pakistan when fundamentals data for this market is added. All Pakistan stocks.
Fair value estimate · limited data
Data under review
Too few of our models give a usable value for this company, so we show no number rather than a misleading one.
PSX income statement only (no balance sheet or cash flow): only earnings and sales models can be built. Their weights were fitted to a professional consensus-style valuation of Pakistani stocks and checked on stocks that were not used for the fit, but they use no analyst forecasts. Treat this as a rough estimate.
P/S multiple
PKR 31.050
Each model multiplies the company's trailing-twelve-month earnings (or sales) by a multiple that blends its own current multiple, its own history and its sector median. Earnings per share by fiscal year, newest first: -0.28, -7.11, 1.04, -1.02. Source: statements and price from the Pakistan Stock Exchange portal and end-of-day data. A model estimate, not a price target or advice. How it works.
Factor ratings for LIVEN
Each factor is rated by where LIVEN stands among the 14 stocks of its PSX sector (Pharmaceuticals; all PSX stocks when the sector is too small for a fair comparison).
Rating against the group
Goodthe top third of these stocks
Averagethe middle third of these stocks
Badthe bottom third of these stocks
"Beats" is the share of those stocks it is ahead of.
For valuation factors Good means cheaper than most of the group, which is not the same as a bargain.
In total: 0 Good · 1 Average · 7 Bad of 8
Growth: 0 · 0 · 1
Profitability: 0 · 0 · 1
Valuation: 0 · 0 · 1
Price risk and momentum: 0 · 0 · 3
Liquidity: 0 · 1 · 1
| Factor | LIVEN | Rating | Group median |
|---|---|---|---|
| Growth | |||
| Sales growth, last financial year | −16.9% | Bad beats 4% | +11.0% |
| Profitability | |||
| Net profit margin | -29.4% | Bad beats 4% | 10.0% |
| Valuation | |||
| Price / sales | 32.4x | Bad beats 4% | 1.2x |
| Price risk and momentum | |||
| Volatility, 1 year | 52.3% | Bad beats 11% | 36.4% |
| Worst drawdown, 1 year | −57.0% | Bad beats 4% | −35.3% |
| 12-month return, skipping the last month | −48.9% | Bad beats 4% | −17.6% |
| Liquidity | |||
| Average daily value traded | PKR 1.1M | Bad beats 4% | PKR 15.8M |
| Days with no trading | 0.0% | Average beats 50% | 0.0% |
Built from the income-statement summary the Pakistan Stock Exchange publishes (sales, profit and EPS for up to four financial years, trailing P/E, market value) and our own end-of-day prices. The PSX portal has no balance sheet or cash flow, so there are no debt, cash-flow or book-value factors. A factor is left out when its data is missing or meaningless (for example a P/E on a loss). These ratings compare companies with each other and describe the past; they are not a forecast, a recommendation or part of the Market X-Ray.
Price chart
52-wk range 27.82 – 67.10 Daily closes, split-adjusted
Signals
50-day average31.89
200-day average37.59
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)1.60
Technical summary
Daily
Bearish
2 bullish · 4 neutral · 10 bearish
Weekly
Strongly bearish
0 bullish · 1 neutral · 11 bearish
Monthly
Strongly bearish
0 bullish · 1 neutral · 7 bearish
Moving averages (daily)
| SMA 10 | 31.20 | Bearish |
| EMA 10 | 30.90 | Bullish |
| SMA 20 | 31.01 | Bearish |
| EMA 20 | 31.09 | Bearish |
| SMA 50 | 31.89 | Bearish |
| EMA 50 | 32.15 | Bearish |
| SMA 100 | 34.84 | Bearish |
| EMA 100 | 34.25 | Bearish |
| SMA 200 | 37.59 | Bearish |
| EMA 200 | 39.16 | Bearish |
Oscillators (daily)
| RSI (14) | 47.28 | Neutral |
| MACD (12, 26) | -0.31 | Bearish |
| Momentum (12) | 1.88 | Bullish |
| Stochastic %K (14) | 40.47 | Neutral |
| Williams %R (14) | -59.53 | Neutral |
| CCI (20) | -6.76 | Neutral |
Pivot points (classic, last session)
S3 28.29 | S2 29.22 | S1 30.08 | Pivot 31.01 | R1 31.87 | R2 32.80 | R3 33.66 |
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in PKR. Educational only, not financial advice.